Targeting the H3K4me3-HNRNPC-CD24 Axis Overcomes Stemness and Immunosuppression in Hepatocellular Carcinoma.
The H3K4me3-HNRNPC-CD24 axis is unveiled as a central epigenetic and post-transcriptional regulatory pathway that coordinately drives HCC stemness and immune evasion, nominating HNRNPC-targeted nanotherapy as a promising strategy for advanced HCC.